Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.

6 Around 80-85% of all lung cancers are non-small cell lung cancer (NSCLC) 7, and most cases of lung cancer in non-smokers ...

Dr. Nilanju Sarmah, Head R&D and Academics, Metropolis Healthcare Limited Lung cancer is the leading cause of cancer-related ...

Chavez, MD, discusses the current approach to managing recurrent small cell lung cancer especially in patients who have ...

In a study led by researchers at the NUS Yong Loo Lin School of Medicine, extracellular vesicles loaded with customizable ...

There are more than 200 different types of cancer and experts say there are some early warning signs people are "most likely ...

Bristol Myers Squibb on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended expanded approval of its Augtyro cancer drug in a pair of indications.

November is Lung Cancer Awareness Month, and early detection is in the air. According to the Centers for Disease Control, ...

Male sex was also shown to be an independent risk factor for longer hospital stays and increased hospitalization costs at ...

Content by Intermountain Health Regional Communications. Did you know that raising awareness and encouraging screening can ...

In operable non-small cell lung cancer (NSCLC), molecular residual disease (MRD) detection via circulating tumor DNA (ctDNA) ...

Study results show that a portable breath analysis device designed for early detection of non–small cell lung cancer may distinguish between patients with the disease and healthy individuals.